The NanoAssemblr platform enables research of the genetic basis of disease and scaling of nanoparticle drug formulations. Precision NanoSystems Inc. (PNI) creates innovative solutions that empower researchers to harness powerful nanotechnology to transform our understanding and treatment of diseases. PNI’s NanoAssemblr™ Transfection Reagents use nanomedicine technology to deliver genetic materials in primary cells in vitr...
The NanoAssemblr platform enables research of the genetic basis of disease and scaling of nanoparticle drug formulations. Precision NanoSystems Inc. (PNI) creates innovative solutions that empower researchers to harness powerful nanotechnology to transform our understanding and treatment of diseases. PNI’s NanoAssemblr™ Transfection Reagents use nanomedicine technology to deliver genetic materials in primary cells in vitro and in vivo, enabling disease researchers to easily study gene function in high-value models of disease.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.